WO1992019600A1 - Preparation of n-acylimidazoles - Google Patents

Preparation of n-acylimidazoles Download PDF

Info

Publication number
WO1992019600A1
WO1992019600A1 PCT/US1992/003322 US9203322W WO9219600A1 WO 1992019600 A1 WO1992019600 A1 WO 1992019600A1 US 9203322 W US9203322 W US 9203322W WO 9219600 A1 WO9219600 A1 WO 9219600A1
Authority
WO
WIPO (PCT)
Prior art keywords
anhydride
recited
carbonyldiimidazole
carboxylic
groups
Prior art date
Application number
PCT/US1992/003322
Other languages
French (fr)
Inventor
Michael Wendell Johnson West
Original Assignee
E.I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E.I. Du Pont De Nemours And Company filed Critical E.I. Du Pont De Nemours And Company
Priority to DE69213447T priority Critical patent/DE69213447T2/en
Priority to EP92911954A priority patent/EP0583375B1/en
Priority to JP4511895A priority patent/JPH06507411A/en
Publication of WO1992019600A1 publication Critical patent/WO1992019600A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Definitions

  • N-acylimidazoles which gives only easily removable CO 2 as a byproduct, and fully utilizes all of the imidazole groups in the carbonyldiimidazole (all of the imidazole groups become N-acylimidazole).
  • This invention concerns a process for the
  • N-acylimidazoles comprising, contacting a carboxylic anhydride with a carbonyldiimidazole.
  • This invention concerns the production of
  • N-acylimidazoles by the reaction of a carboxylic acid
  • the carbonyldiimidazole has the formula
  • the imidazole rings of the carbonyldimidazole may be substituted in the 2, 4 or 5 position. It is preferred that in the carbonyldiimidazole both imidazole rings are unsubstituted, that is the compound 1,1'-carbonyldimidazole.
  • N-acylimidazole is meant a compound of the type
  • an acyl group is bound to the 1 position of an imidazole ring.
  • the group R 1 is hydrocarbyl, which may be substituted with various substituents.
  • the various substituents on the imidazole ring or attached to the group R 1 should be inert under process conditions.
  • the group R 1 is derived from the carboxylic
  • Carboxylic anhydrides are well known to those skilled in the art and contain the group -C(O)-O-C(O)-, where the free bonds are to hydrocarbyl or substituted hydrocarbyl groups, such as the group R 1 .
  • Carboxylic anhydrides may be cyclic or acyclic.
  • the carboxylic anhydride may have the formula R 1 C(O)-O-C(O)R 1 , wherein each R 1 is independently hydrocarbyl, or both hydrocarbyl groups R 1 may be joined to each other to form a cyclic anhydride.
  • acyclic carboxylic anhydrides useful in the instant process are acetic anhydride, perfluorobutyric anhydride, trifluoroacetic anhydride, benzoic anhydride, hexanoic anhydride, and methacrylic anhydride. These acyclic anhydrides may also be so-called mixed
  • anhydrides such as acetic propanoic anhydride.
  • mixed anhydrides two N-acylimidazoles will be obtained, each derived from one of the acyl groups in the mixed anhydride.
  • Symmetrical anhydrides both R 1 groups the same are preferred.
  • a typical reaction of a CDI with an acyclic carboxylic anhydride is:
  • Cyclic anhydrides are also useful in the instant process.
  • examples of such cyclic anhydrides include, but are not limited to, succinic anhydride, maleic anhydride, phthalic anhydride, and itaconic anhydride.
  • a cyclic anhydride reacts with a CDI a compound containing two N-acylimidazole groups will be produced (assuming only one anhydride group per cyclic anhydride molecule), since the anhydride groups are also connected by the cyclic structure.
  • reaction of phthalic anhydride with a CDI proceeds as follows:
  • substituents that may be present either in the carboxylic anhydride (for example, the group R 1 ) or in the 2, 4 or 5 positions of the imidazole ring of the CDI (and hence also present in the N-acylimidazole product), include, but are not limited to ether, ester, amide, fluoro, chloro, bromo, and iodo, and for substitution in the imidazole ring, hydrocarbyl. Any combination of substituents in any of these
  • the carboxylic anhydride may be part of a much larger molecule, such as a polymer.
  • the carboxylic anhydride may be maleic anhydride or itaconic anhydride that has been (usually free radically)
  • the carboxylic anhydride may also contain more than one anhydride group, as in
  • anhydride groups in the copolymer are cyclic.
  • the ratio of total anhydride groups to the CDI is about 1. This insures the most efficient use of the starting materials, and obviates the need for removal of
  • solvents is optional, and any solvent used should be aprotic. Solvents are particularly useful when the ingredients are not miscible or one or both of the ingredients are solid at the process temperature.
  • a useful solvent is methylene chloride.
  • Useful solvent types include halocarbons, esters, aromatics, etc.
  • Protic solvents such as alcohols, water, primary and secondary amines should be avoided.
  • the product N-acylimidazole may be used directly as made in the process, since the only byproduct is gaseous CO 2 . If a solvent is used, it may be removed by
  • N-acylimidazole may be purified by distillation or crystallization, as
  • N-acylimidazoles are useful intermediates for the preparation esters, amides, peptides, carboxylic anhydrides, and other types of organic compounds. This reference also describes the preparation of CDIs.

Abstract

A process for the production of N-acylimidazoles by the reaction of a carboxylic anhydride with carbonyldiimidazole is disclosed. The products are useful as chemical intermediates.

Description

TITLE
PREPARATION OF N-ACYLIMIDAZOLES
BACKGROUND OF THE INVENTION
Field of the Invention
A process for the production of N-acylimidazoles by the reaction of a carboxylic anhydride with a
carbonyldiimidazole is disclosed. The products are useful as chemical intermediates.
Technical Background
H. A. Staab, Angew. Chem. Intl. Ed., vol. 1, pp. 351-367 (1962) describes various syntheses and uses for N-acylimidazoles (called therein "imidazolides"). At pp. 355-56 the reaction of carbonyldiimidazoles with carboxylic acids, to give one mole of N-acylimidazole, one mole of CO2 and one mole of imidazole per mole of starting material is described. No mention is made in this article of reacting carboxylic anhydrides with a carbonyl-diimidazole to form N-acylimidazoles.
It is the object of the present invention to provide a simple method for the preparation of
N-acylimidazoles which gives only easily removable CO2 as a byproduct, and fully utilizes all of the imidazole groups in the carbonyldiimidazole (all of the imidazole groups become N-acylimidazole).
SUMMARY OF THE TNVENTTON
This invention concerns a process for the
production of N-acylimidazoles, comprising, contacting a carboxylic anhydride with a carbonyldiimidazole.
DETAILS OF THE INVENTION
This invention concerns the production of
N-acylimidazoles by the reaction of a carboxylic
anhydride with a carbonyldiimidazole (herein sometimes abbreviated CDI). The carbonyldiimidazole has the formula
Figure imgf000004_0001
The imidazole rings of the carbonyldimidazole (and the resulting acylimidazole) may be substituted in the 2, 4 or 5 position. It is preferred that in the carbonyldiimidazole both imidazole rings are unsubstituted, that is the compound 1,1'-carbonyldimidazole.
By the term N-acylimidazole is meant a compound of the type
Figure imgf000004_0002
wherein an acyl group is bound to the 1 position of an imidazole ring. The group R1 is hydrocarbyl, which may be substituted with various substituents. The various substituents on the imidazole ring or attached to the group R1 should be inert under process conditions.
The group R1 is derived from the carboxylic
anhydride used in the process. Carboxylic anhydrides are well known to those skilled in the art and contain the group -C(O)-O-C(O)-, where the free bonds are to hydrocarbyl or substituted hydrocarbyl groups, such as the group R1. Carboxylic anhydrides may be cyclic or acyclic. Thus the carboxylic anhydride may have the formula R1C(O)-O-C(O)R1, wherein each R1 is independently hydrocarbyl, or both hydrocarbyl groups R1 may be joined to each other to form a cyclic anhydride. Examples of acyclic carboxylic anhydrides useful in the instant process are acetic anhydride, perfluorobutyric anhydride, trifluoroacetic anhydride, benzoic anhydride, hexanoic anhydride, and methacrylic anhydride. These acyclic anhydrides may also be so-called mixed
anhydrides, such as acetic propanoic anhydride. In the case of mixed anhydrides, two N-acylimidazoles will be obtained, each derived from one of the acyl groups in the mixed anhydride. Symmetrical anhydrides (both R1 groups the same) are preferred. A typical reaction of a CDI with an acyclic carboxylic anhydride is:
Figure imgf000005_0001
Cyclic anhydrides are also useful in the instant process. Examples of such cyclic anhydrides include, but are not limited to, succinic anhydride, maleic anhydride, phthalic anhydride, and itaconic anhydride. When a cyclic anhydride reacts with a CDI, a compound containing two N-acylimidazole groups will be produced (assuming only one anhydride group per cyclic anhydride molecule), since the anhydride groups are also connected by the cyclic structure. For example, reaction of phthalic anhydride with a CDI proceeds as follows:
Figure imgf000005_0002
Examples of suitable substituents that may be present either in the carboxylic anhydride (for example, the group R1) or in the 2, 4 or 5 positions of the imidazole ring of the CDI (and hence also present in the N-acylimidazole product), include, but are not limited to ether, ester, amide, fluoro, chloro, bromo, and iodo, and for substitution in the imidazole ring, hydrocarbyl. Any combination of substituents in any of these
positions may be present.
The carboxylic anhydride may be part of a much larger molecule, such as a polymer. For example, the carboxylic anhydride may be maleic anhydride or itaconic anhydride that has been (usually free radically)
copolymerized with other monomers, so that the anhydride group remains intact. The carboxylic anhydride may also contain more than one anhydride group, as in
pyromellitic anhydride, or a plurality of anhydride groups as in the copolymers mentioned above. It is preferred if the anhydride groups in the copolymer are cyclic.
While virtually any ratio of the ingredients will yield the desired N-acylimidazoles, it is preferred if the ratio of total anhydride groups to the CDI is about 1. This insures the most efficient use of the starting materials, and obviates the need for removal of
unreacted starting materials, i.e., yields relatively pure N-acylimidazole directly. Of course if it is desired to react only part of the anhydride groups (as in a polymer containing anhydride), less CDI would be used.
While temperature is not critical, convenient reaction rates are obtained at about 0°C to about 200°C, preferably about 20°C to about 100°C. The use of
solvents is optional, and any solvent used should be aprotic. Solvents are particularly useful when the ingredients are not miscible or one or both of the ingredients are solid at the process temperature. A useful solvent is methylene chloride. Useful solvent types include halocarbons, esters, aromatics, etc.
Protic solvents such as alcohols, water, primary and secondary amines should be avoided.
It is preferable to avoid water vapor, so the process is conveniently carried out under a blanket of nitrogen, argon, or CO2. Agitation to achieve mixing of the ingredients is preferred.
The product N-acylimidazole may be used directly as made in the process, since the only byproduct is gaseous CO2. If a solvent is used, it may be removed by
distillation. The product N-acylimidazole may be purified by distillation or crystallization, as
appropriate.
As described by H. A. Staab (supra, which is hereby included by reference), N-acylimidazoles are useful intermediates for the preparation esters, amides, peptides, carboxylic anhydrides, and other types of organic compounds. This reference also describes the preparation of CDIs.
In the following Examples, the CDI used is
1,1'-carbonyldiimidazole. All parts are parts by weight.
EXAMPLE 1
N-Acetylimidazole
Into 13 parts methylene chloride containing 1.86 parts carbonyldiimidazole, 1.14 parts acetic anhydride was slowly added. After 1 hour, the mixture became cloudy. The solvent was removed to obtain 2.37 parts crude acetylimidazole, from which 1.31 parts
recrystallized product was obtained from toluene.
1H-NMR and melting point were consistent with authentic acetylimidazole. EXAMPLE 2
N-Methacryloylimidazole
Into 39 parts methylene chloride containing 9.83 parts carbonyldiimidazole, 9.35 parts methacrylic anhydride was slowly added. Gas evolution began
immediately; after 1 hour the slurried mixture became clear, and after 3 hours the gas evolution was complete. The solvent was removed to obtain 17 parts crude
product. A 15 part fraction was distilled at 0.25 torr to obtain 6.9 parts of a material distilling from 44 to 60°C. IR, 1H-NMR, 13C-NMR were consistent with authentic material prepared by other routes (J. Polym. Sci.,
Polym. Chem. Ed., Vol. 12, pp. 2453-2455 (1974)).
EXAMPLE 3
N-Benzoylimidazole
Into 132 parts methylene chloride containing 8.16 parts carbonyldiimidazole, 11.31 parts benzoic anhydride in 66 parts methylene chloride was added. The resulting mixture was refluxed 5 hours until gas evolution ceased. The yield after removal of solvent at reduced pressure was 19.31 parts crude material, demonstrated as
predominantly benzoylimidazole by IR, GC-MS, 1H-NMR, and 13C-NMR accompanied by some dichloromethane. The
compound is known, Chem. Ber., Vol. 95, pp. 1275-1283 (1961).
EXAMPLE 4
Polymeric N-Acylimidazole
Into a solution of 5.04 parts SMA-100 styrene/maleic anhydride copolymer (Atochem, Inc.) in 50 parts dichloromethane, there was added a slurry of 5.09 parts carbonyldiimidazole in 10.1 parts methylene chloride.
The resulting mixture was refluxed for two hours. The solids dissolved, gas was generated, and the mixture turned a very deep red. The IR absorbances at 1780 and 1857 cm-1 (SMA-1000) and 1754 cm-1 (carbonyldiimidazole) were completely replaced in the product by absorbance peaks at 1758, 1780, and 1730 cm-1.
EXAMPLE 5
N-Heptafluorobutyroylimidazole
Into a mixture of 10 parts perfluorobutyric anhydride in 40 parts of dichloromethane, there was added a slurry of 4.0 parts carbonyldiimidazole in 10.25 parts methylene chloride. The resulting mixture was refluxed for one hour. Gas generation was noted during the addition and reflux steps. The IR absorbances at 1798 and 1866 cm-1 (anhydride) and 1754 cm-1 (carbonyldiimidazole) were replaced in the product by a peak at 1754 cm-1. The yield after removal of solvent by vacuum was 12.3 parts.
Although preferred embodiments of the invention have been described hereinabove, it is to be understood that there is no intention to limit the invention to the precise constructions herein disclosed, and it is to be further understood that the right is reserved to all changes coming within the scope of the invention as defined by the appended claims.

Claims

What is claimed is: 1. A process for the production of N-acylimidazoles, comprising, contacting a carboxylic anhydride with a carbonyldiimidazole.
2. The process as recited in Claim 1 carried out in the presence of an aprotic solvent.
3. The process as recited in Claim 1 carried out at a temperature of about 0°C to about 200°C.
4. The process as recited in Claim 3 carried out at a temperature of about 20°C to about 100°C.
5. The process as recited in Claim 2 carried out at a temperature of about 0°C to about 200°C.
6. The process as recited in Claim 1 wherein the ratio of carboxylic anhydride groups to carbonyldiimidazole is about 1.
7. The process as recited in Claim 3 wherein the ratio of carboxylic anhydride groups to carbonyldiimidazole is about 1.
8. The process as recited in Claim 1 wherein said carboxylic anhydride has the formula R1C(O)-O-C(O)R1, wherein each R1 is independently hydrocarbyl, or both hydrocarbyl groups R1 are joined to each other to form a cyclic anhydride.
9. The process as recited in Claim 7 wherein said carboxylic anhydride has the formula R1C(O)-O-C(O)R1, wherein each R1 is independently hydrocarbyl, or both hydrocarbyl groups R1 are joined to each other to form a cyclic anhydride.
10. The process as recited in Claim 8 wherein each R1 is the same.
11. The process as recited in Claim 9 wherein each R1 is the same.
12. The process as recited in Claim 8 wherein said R1 contains one or more substituents selected from the group consisting of ether, ester, amide, fluoro, chloro, bromo, and iodo.
13. The process as recited in Claim 9 wherein said R1 contains one or more substituents selected from the group consisting of ether, ester, amide, fluoro, chloro, bromo, and iodo.
14. The process as recited in Claim 1 wherein said carboxylic anhydride is elected from the group
consisting of acetic anhydride, perfluorobutyric
anhydride, trifluoroacetic anhydride, benzoic anhydride, hexanoic anhydride, methacrylic anhydride, succinic anhydride, maleic anhydride, phthalic anhydride, and itaconic anhydride.
15. The process as recited in Claim 7 wherein said carboxylic anhydride is elected from the group
consisting of acetic anhydride, perfluorobutyric
anhydride, trifluoroacetic anhydride, benzoic anhydride, hexanoic anhydride, methacrylic anhydride, succinic anhydride, maleic anhydride, phthalic anhydride, and itaconic anhydride.
16. The process as recited in Claim 1 wherein said carbonyldiimidazole is 1,1"-carbonyldimidazole.
17. The process as recited in Claim 2 wherein said aprotic solvent is methylene chloride.
18. The process as recited in Claim 1 wherein said anhydride is a copolymer containing a plurality of cyclic anhydride groups.
19. The process as described in Claim 9 wherein said carbonyldiimidazole is 1,1'-carbonyldiimidazole.
PCT/US1992/003322 1988-12-15 1992-04-29 Preparation of n-acylimidazoles WO1992019600A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE69213447T DE69213447T2 (en) 1988-12-15 1992-04-29 PRODUCTION OF N-ACYLIMIDAZOLES
EP92911954A EP0583375B1 (en) 1988-12-15 1992-04-29 Preparation of n-acylimidazoles
JP4511895A JPH06507411A (en) 1988-12-15 1992-04-29 Production of N-acylimidazole

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/284,896 US5084280A (en) 1988-12-15 1988-12-15 Wood preservation composition and method
US695,157 1991-05-03
US07/695,157 US5145983A (en) 1988-12-15 1991-05-03 Preparation of N-acylimidazoles

Publications (1)

Publication Number Publication Date
WO1992019600A1 true WO1992019600A1 (en) 1992-11-12

Family

ID=40290953

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/003322 WO1992019600A1 (en) 1988-12-15 1992-04-29 Preparation of n-acylimidazoles

Country Status (6)

Country Link
US (2) US5084280A (en)
EP (2) EP0539619A1 (en)
JP (1) JPH06507411A (en)
CA (2) CA2004637C (en)
DE (2) DE4126986A1 (en)
WO (1) WO1992019600A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084280A (en) * 1988-12-15 1992-01-28 Chapman Chemical Company Wood preservation composition and method
US5470986A (en) * 1994-06-27 1995-11-28 E. I. Du Pont De Nemours And Company Imidazolium hardeners for hydrophilic colloid
US5846305A (en) * 1996-01-16 1998-12-08 Michael Wall & Sons Enterprises Ltd. Liquid wood preservative solution
DE19614799A1 (en) * 1996-04-15 1997-10-16 Ostermann & Scheiwe Gmbh & Co Process for the protection of laminated glulam and glulam from rot
DE19724884A1 (en) * 1997-06-12 1998-12-17 Basf Ag Carbonyldiimidazoles, esters derived therefrom and processes for their preparation
SI1255752T1 (en) * 2000-02-15 2007-12-31 Pharmacia & Upjohn Co Llc Pyrrole substituted 2-indolinone protein kinase inhibitors
AR042586A1 (en) 2001-02-15 2005-06-29 Sugen Inc 3- (4-AMIDOPIRROL-2-ILMETILIDEN) -2-INDOLINONE AS INHIBITORS OF PROTEIN KINASE; YOUR PHARMACEUTICAL COMPOSITIONS; A METHOD FOR THE MODULATION OF THE CATALYTIC ACTIVITY OF PROTEINQUINASE; A METHOD TO TREAT OR PREVENT AN AFFECTION RELATED TO PROTEINQUINASE
CA2357357C (en) 2001-09-17 2010-03-16 Genics Inc. Method of treating building materials with boron and building materials
EP1434774A1 (en) 2001-10-10 2004-07-07 Sugen, Inc. 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
GB0700857D0 (en) * 2007-01-17 2007-02-21 Betts John A Preservative compositions for wood and like materials
US8221797B2 (en) * 2007-02-09 2012-07-17 Osmose, Inc. Wood preserving composition for treatment of in-service poles, posts, piling, cross-ties and other wooded structures
CN102633725A (en) * 2012-04-10 2012-08-15 浏阳坛青达康医药科技有限公司 Synthetic method of N-heptafluorobutyrylimidazole
US9303169B2 (en) 2014-06-16 2016-04-05 Osmose Utilities Services, Inc. Controlled release, wood preserving composition with low-volatile organic content for treatment in-service utility poles, posts, pilings, cross-ties and other wooden structures
CN110568104A (en) * 2019-09-24 2019-12-13 杭州市质量技术监督检测院 Method for simultaneously measuring migration volumes of various chlorinated phenols in wooden tableware

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2703023A1 (en) * 1977-01-26 1978-07-27 Basf Ag FURANDERIVATE
CA1174004A (en) * 1982-09-28 1984-09-11 John Krzyzewski Arsenical creosote wood preservative
US5084280A (en) * 1988-12-15 1992-01-28 Chapman Chemical Company Wood preservation composition and method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANGEWANDTE CHEMIE. INTERNATIONAL EDITION. vol. 1, 1962, WEINHEIM DE pages 351 - 367; cited in the application *
SYNTHESIS. vol. 10, 1990, STUTTGART DE pages 951 - 955; *
TETRAHEDRON, (INCL. TETRAHEDRON REPORTS) vol. 36, no. 17, 1980, OXFORD GB pages 2505 - 2511; *

Also Published As

Publication number Publication date
CA2004637A1 (en) 1990-06-15
JPH06507411A (en) 1994-08-25
DE4126986A1 (en) 1993-02-18
DE69213447D1 (en) 1996-10-10
EP0539619A1 (en) 1993-05-05
US5084280A (en) 1992-01-28
DE69213447T2 (en) 1997-02-20
US5145983A (en) 1992-09-08
EP0583375B1 (en) 1996-09-04
EP0583375A1 (en) 1994-02-23
CA2004637C (en) 1996-12-24
CA2109229A1 (en) 1992-11-04

Similar Documents

Publication Publication Date Title
EP0583375B1 (en) Preparation of n-acylimidazoles
Barstow et al. Simple method for the synthesis of amides
JPH093027A (en) Synthesizing method for fluorinated nitrile compound
HU200747B (en) Process for producing new nitroaliphatic compounds
US5990321A (en) Monoesters and macrocyclic diester of phthalic acid and synthesis thereof
US5110964A (en) Process for producing ferrocenoyl derivatives
US4138584A (en) Production of chrysanthemic acid esters and homologues thereof
US5461157A (en) Process for preparing pyrrolidinylacetamide derivatives
US5144047A (en) Process for the production of tetronic acid alkyl esters
US3423421A (en) Substituted dihydro-11h-isoindolo(2,1-a) benzimidazol - 11 - ones and related compounds
EP0396564A1 (en) Process for the preparation of stilbenedicarboxylate derivatives
Yoshida et al. Electrophilic substitution of 4H-cyclopenta [def] phenanthrene. Friedel-Crafts acetylation
EP0047674B1 (en) Novel process for preparing isoindolin derivatives
GB2143814A (en) Quinazolines
US4130717A (en) Process and intermediates for isoindole derivatives
US4089875A (en) Process and intermediates for isoindole derivatives
USH53H (en) Processes for producing herbicide intermediates
US4150043A (en) 0-(2,3-Epoxypropyl)-hydroximic acid esters
CA1110247A (en) Process for preparing certain ethyleneglycol diesters
US4785120A (en) Process for preparing substituted phthalic anhydrides
JP2635632B2 (en) Method for producing triazole derivative
US5021584A (en) Process for preparation of 1-benzylimidazole compound
JPH0491055A (en) Production of succinic diester and its derivative
JPS6016975A (en) N-imidazolyl derivatives of bicyclic compounds and manufacture
EP0255384B1 (en) 4,4-bis-(carboxyphenylsulfonyl)diphenyl ethers, process for their preparation and their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2109229

Country of ref document: CA

Ref document number: 1992911954

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992911954

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1992911954

Country of ref document: EP